MASH / MASLD

>

The HCPLive MASH & MASLD page is a comprehensive resource for clinical news and insights on metabolic dysfunction-associated steatotic liver disease and steatohepatitis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for fatty liver disease, steatohepatitis, and more.

Latest News

| Image Credit: LinkedIn
Microbiota-Focused Dietary Modulation May Improve MAFLD Management

May 19th 2024

Microbiota differences between individuals with and without MAFLD were associated with dietary intake and clinical outcomes.

Rohit Loomba, MD | Credit: ACG
Study Assesses Predictive Markers of Resmetirom Histological Response in MAESTRO-NASH

May 19th 2024

Wei-Fan Hsu, MD | Credit: LinkedIn
Metabolic Dysfunction Increases Risk of Liver-Related Events After Achieving SVR

May 15th 2024

Florian Koutny, MD | Credit: ResearchGate
Poorly Controlled Type 1 Diabetes Associated with MASLD in Children, Adolescents

April 12th 2024

Liver | Credit: Adobe Stock
HBV Viral Load, Surface Antigen Positivity Not Independently Associated with NAFLD

April 10th 2024

© 2024 MJH Life Sciences

All rights reserved.